Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim F Greten

Showing results (71-80 of 222) with videos related to

Pageof 23
Sort By:
Pancreas|May 24, 2016
Pancreatic Squamous Cell Carcinoma: A Population-Based Study of Epidemiology, Clinicopathologic Characteristics and OutcomesOxana V Makarova-Rusher, Susanna Ulahannan, Tim F Greten, et al.
Journal of Hepatocellular Carcinoma|August 3, 2023
Hispanic Individuals are Underrepresented in Phase III Clinical Trials for Advanced Liver Cancer in the United StatesCecilia Monge, J Alberto Maldonado, Katherine A McGlynn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Maintenance of peritoneal B-1a lymphocytes in the absence of the spleenKarsten Kretschmer, Jana Stopkowicz, Stephan Scheffer, et al.
Molecular Oncology|April 23, 2009
Circulating tumour cells as a predictive factor for response to systemic chemotherapy in patients with advanced colorectal cancerSilke Lankiewicz, Silke Zimmermann, Christiane Hollmann, et al.
Journal of Gastroenterology and Hepatology|August 31, 2011
Critical appraisal of clinical practice guidelines for diagnosis and treatment of hepatocellular carcinomaSebastian Schmidt, Markus Follmann, Nisar Malek, et al.
Methods and Protocols|December 27, 2024
Liver Cancer Neuroscience: Regulating Liver Tumors via Selective Hepatic VagotomyKylynda C Bauer, Shadin Ghabra, Chi Ma, et al.
Gastroenterology|October 6, 2018
Targeted and Immune-Based Therapies for Hepatocellular CarcinomaTim F Greten, Chunwei Walter Lai, Guangfu Li, et al.
Blood|April 16, 2011
Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cellsBastian Hoechst, Jaba Gamrekelashvili, Michael P Manns, et al.
Trends in Immunology|June 15, 2024
Innate-like T cells in liver diseaseAlbert Ying-Po Yang, Kilian Wistuba-Hamprecht, Tim F Greten, et al.
Immunology|May 3, 2007
Peptide-beta2-microglobulin-major histocompatibility complex expressing cells are potent antigen-presenting cells that can generate specific T cellsSonja Obermann, Susanne Petrykowska, Michael P Manns, et al.
Pageof 23

Showing results (71-80 of 222) with videos related to

Sort By:
Pageof 23
Pancreas|May 24, 2016
Pancreatic Squamous Cell Carcinoma: A Population-Based Study of Epidemiology, Clinicopathologic Characteristics and OutcomesOxana V Makarova-Rusher, Susanna Ulahannan, Tim F Greten, et al.
Journal of Hepatocellular Carcinoma|August 3, 2023
Hispanic Individuals are Underrepresented in Phase III Clinical Trials for Advanced Liver Cancer in the United StatesCecilia Monge, J Alberto Maldonado, Katherine A McGlynn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Maintenance of peritoneal B-1a lymphocytes in the absence of the spleenKarsten Kretschmer, Jana Stopkowicz, Stephan Scheffer, et al.
Molecular Oncology|April 23, 2009
Circulating tumour cells as a predictive factor for response to systemic chemotherapy in patients with advanced colorectal cancerSilke Lankiewicz, Silke Zimmermann, Christiane Hollmann, et al.
Journal of Gastroenterology and Hepatology|August 31, 2011
Critical appraisal of clinical practice guidelines for diagnosis and treatment of hepatocellular carcinomaSebastian Schmidt, Markus Follmann, Nisar Malek, et al.
Methods and Protocols|December 27, 2024
Liver Cancer Neuroscience: Regulating Liver Tumors via Selective Hepatic VagotomyKylynda C Bauer, Shadin Ghabra, Chi Ma, et al.
Gastroenterology|October 6, 2018
Targeted and Immune-Based Therapies for Hepatocellular CarcinomaTim F Greten, Chunwei Walter Lai, Guangfu Li, et al.
Blood|April 16, 2011
Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cellsBastian Hoechst, Jaba Gamrekelashvili, Michael P Manns, et al.
Trends in Immunology|June 15, 2024
Innate-like T cells in liver diseaseAlbert Ying-Po Yang, Kilian Wistuba-Hamprecht, Tim F Greten, et al.
Immunology|May 3, 2007
Peptide-beta2-microglobulin-major histocompatibility complex expressing cells are potent antigen-presenting cells that can generate specific T cellsSonja Obermann, Susanne Petrykowska, Michael P Manns, et al.
Pageof 23